These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 28497874)

  • 41. Psoriasis Area and Severity Index 75 rate of classical inpatient dithranol therapy under daily life conditions.
    Painsi C; Patscheider M; Inzinger M; Huegel R; Lange-Asschenfeldt B; Quehenberger F; Wolf P
    Br J Dermatol; 2015 Sep; 173(3):815-7. PubMed ID: 25704591
    [No Abstract]   [Full Text] [Related]  

  • 42. The cross-talk between renal function, inflammation and psoriasis vulgaris.
    Coimbra S; Oliveira H; Rocha-Pereira P; Figueiredo A; Santos-Silva A
    Br J Dermatol; 2017 Mar; 176(3):829-831. PubMed ID: 27479860
    [No Abstract]   [Full Text] [Related]  

  • 43. Aberrant B-cell Subsets and Immunoglobulin Levels in Patients with Moderate-to-severe Psoriasis.
    Kahlert K; Grän F; Muhammad K; Benoit S; Serfling E; Goebeler M; Kerstan A
    Acta Derm Venereol; 2019 Feb; 99(2):226-227. PubMed ID: 30320869
    [No Abstract]   [Full Text] [Related]  

  • 44. Alteration of serum thymus and activation-regulated chemokine level during biologic therapy for psoriasis: Possibility as a marker reflecting favorable response to anti-interleukin-17A agents.
    Shibuya T; Honma M; Iinuma S; Iwasaki T; Takahashi H; Ishida-Yamamoto A
    J Dermatol; 2018 Jun; 45(6):710-714. PubMed ID: 29655215
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Erythrodermic psoriasis treated with ustekinumab: an Italian multicenter retrospective analysis.
    Pescitelli L; Dini V; Gisondi P; Loconsole F; Piaserico S; Piccirillo A; Stinco G; Errichetti E; Talamonti M; Tripo L; Volpi W; Prignano F
    J Dermatol Sci; 2015 May; 78(2):149-51. PubMed ID: 25681953
    [No Abstract]   [Full Text] [Related]  

  • 46. A reliability study using Network Oriented Research Assistant (NORA
    Jeong D; Aralis H; Bruhn KW; Cotliar J; Craft N; DeLuca IJ; Hamidi R; Nguyen K; Patel VA; Sofen H; Tan BH; David CV
    Br J Dermatol; 2019 Jul; 181(1):214-215. PubMed ID: 30703265
    [No Abstract]   [Full Text] [Related]  

  • 47. Clinical significance of serum levels of vascular endothelial growth factor, angiopoietin-1, and angiopoietin-2 in patients with rheumatoid arthritis.
    Kurosaka D; Hirai K; Nishioka M; Miyamoto Y; Yoshida K; Noda K; Ukichi T; Yanagimachi M; Furuya K; Takahashi E; Kingetsu I; Fukuda K; Yamada A
    J Rheumatol; 2010 Jun; 37(6):1121-8. PubMed ID: 20436077
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Correlation Between Dermatology Life Quality Index and Psoriasis Area and Severity Index in Patients with Psoriasis Treated with Ustekinumab.
    Hesselvig JH; Egeberg A; Loft ND; Zachariae C; Kofoed K; Skov L
    Acta Derm Venereol; 2018 Mar; 98(3):335-339. PubMed ID: 29110019
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacogenetics of ustekinumab in patients with moderate-to-severe plaque psoriasis.
    Prieto-Pérez R; Llamas-Velasco M; Cabaleiro T; Solano-López G; Márquez B; Román M; Ochoa D; Talegón M; Daudén E; Abad-Santos F
    Pharmacogenomics; 2017 Jan; 18(2):157-164. PubMed ID: 27977334
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Angiopoietin-1 and -2 as markers for disease severity in hemolytic uremic syndrome induced by enterohemorrhagic Escherichia coli.
    Shimizu M; Inoue N; Kuroda M; Mizuta M; Sugimoto N; Kaneda H; Ohta K; Yachie A
    Clin Exp Nephrol; 2017 Feb; 21(1):76-82. PubMed ID: 26945868
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum Human Beta-Defensin-2 Is a Possible Biomarker for Monitoring Response to JAK Inhibitor in Psoriasis Patients.
    Jin T; Sun Z; Chen X; Wang Y; Li R; Ji S; Zhao Y
    Dermatology; 2017; 233(2-3):164-169. PubMed ID: 28654918
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oral PSORI-CM01, a Chinese herbal formula, plus topical sequential therapy for moderate-to-severe psoriasis vulgaris: pilot study for a double-blind, randomized, placebo-controlled trial.
    Yao DN; Lu CJ; Wen ZH; Yan YH; Xuan ML; Li XY; Li G; He ZH; Xie XL; Deng JW; Guo XF; Ou AH
    Trials; 2016 Mar; 17(1):140. PubMed ID: 26983642
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Different response rates between palmoplantar involvement and diffuse plaque psoriasis in patients treated with infliximab.
    Brunasso AM; Puntoni M; Delfino C; Massone C
    Eur J Dermatol; 2012; 22(1):133-5. PubMed ID: 22134100
    [No Abstract]   [Full Text] [Related]  

  • 54. Relationship between disease severity and fetuin-A levels in patients with psoriasis.
    Shehata WA; Basha MA; Gayed IM; Elhagary SB
    Indian J Dermatol Venereol Leprol; 2020; 86(5):586-588. PubMed ID: 32769317
    [No Abstract]   [Full Text] [Related]  

  • 55. Prognostic significance of the angiopoietin-2/angiopoietin-1 and angiopoietin-1/Tie-2 ratios for early sepsis in an emergency department.
    Fang Y; Li C; Shao R; Yu H; Zhang Q; Zhao L
    Crit Care; 2015 Oct; 19():367. PubMed ID: 26463042
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A semi-mechanistic model to characterize the pharmacokinetics and pharmacodynamics of brodalumab in healthy volunteers and subjects with psoriasis in a first-in-human single ascending dose study.
    Salinger DH; Endres CJ; Martin DA; Gibbs MA
    Clin Pharmacol Drug Dev; 2014 Jul; 3(4):276-83. PubMed ID: 27128833
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Short-contact therapy with tazarotene in psoriasis vulgaris.
    Veraldi S; Schianchi R
    Dermatology; 2003; 206(4):347-8. PubMed ID: 12771482
    [No Abstract]   [Full Text] [Related]  

  • 58. Polyphenotypic Psoriasis: A Report from the GRAPPA 2016 Annual Meeting.
    Kaskas N; Merola JF; Qureshi AA; Paek SY
    J Rheumatol; 2017 May; 44(5):695-696. PubMed ID: 28461530
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Experience with biologics for psoriasis in daily practice: switching is worth a try.
    Lecluse LL; de Groot M; Bos JD; Spuls PI
    Br J Dermatol; 2009 Oct; 161(4):948-51. PubMed ID: 19663876
    [No Abstract]   [Full Text] [Related]  

  • 60. Neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and mean platelet volume in Japanese patients with psoriasis and psoriatic arthritis: Response to therapy with biologics.
    Asahina A; Kubo N; Umezawa Y; Honda H; Yanaba K; Nakagawa H
    J Dermatol; 2017 Oct; 44(10):1112-1121. PubMed ID: 28493493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.